International journal of clinical pharmacy
Responsiveness and minimum important change of the Pharmacotherapeutic Symptom Evaluation-20-Australian version: a tool for measuring changes in medicine-related symptoms over time.
Abebe Basazn Mekuria, Andre Q Andrade, Renly Lim, Debra Rowett, Mariann Hedström, Elizabeth E Roughead
Published: 202510.1007/s11096-025-02045-4
Abstract
INTRODUCTION: Monitoring patient-reported symptoms over time may support early detection of medicine-related harms. The Pharmacotherapeutic Symptom Evaluation-20-Australian version (PHASE-20-Australian version) is an 11-point rating scale designed fo…
Preview only. Read the full abstract at the source